P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

• S. Fried,
• M. J. Besser,
• E. Shkury,
• R. Yerushalmi,
• N. Shem-Tov,
• I. Danylesko,
• E. Jacoby,
• O. Itzhaki,
• R. Shouval,
• M. Kedmi,
• A. Shimoni,
• A. Nagler,
• A. Avigdor

Affiliations

S. Fried

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

M. J. Besser

3 Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel-Aviv

E. Shkury

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

R. Yerushalmi

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

N. Shem-Tov

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

I. Danylesko

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

E. Jacoby

2 Sackler School of Medicine

O. Itzhaki

4 Ella Lemelbaum Institute for Immuno Oncology

R. Shouval

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

M. Kedmi

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

A. Shimoni

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

A. Nagler

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer

A. Avigdor

1 Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer